Solriamfetol 150 MG

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolNCT07484217AXSMPhase 3Recruiting2028-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.